- by Rowan WalrathThe new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein
- by Sarah BranerCompany’s lead candidate is already in a Phase 2 trial for major depressive disorder
- by Rowan WalrathCity Therapeutics inks neuroscience deal 8 months after launch
- by Rowan WalrathRobert F. Kennedy Jr. sidesteps advisory committee in changing immunization schedule
- by Asher Mullard, special to C&ENGlycoEra is using biologics to degrade autoimmune disease targets, starting with IgG4
- by Rowan WalrathAgency appointees appear to sidestep advisory committees
- by Britt E. EricksonAgency convenes panel to discuss inflammation and cancer risks of common anti-sticking agent
- by Max BarnhartA CRISPR-guided transposase called evoCAST inserts genes into human DNA in a single step
- by Rowan WalrathHow industry leaders are trying to work with the White House
- by Louisa Dalton, special to C&ENCryo-EM experts make a movie of influenza’s replication machinery, which could lead to better antivirals
Making chemistry accessible and relevant.